| Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer |
15 |
| Diet and Lifestyle Before and During Pregnancy - Practical Recommendations of the Germany-wide Healthy Start - Young Family Network |
13 |
| Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) - Recommendations for Daily Routine Practice |
11 |
| Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/050) |
10 |
| Low-grade Serous Ovarian Carcinoma |
10 |
| Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus |
10 |
| Update Breast Cancer 2019 Part 3-Current Developments in Early Breast Cancer: Review and Critical Assessment by an International Expert Panel |
9 |
| Peripartum Haemorrhage, Diagnosis and Therapy. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 015/ March 2016) |
9 |
| Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/ November 2017) - Recommendations and Statements for Girls and Women |
9 |
| Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer |
8 |
| Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data |
8 |
| Update Breast Cancer 2019 Part 2-Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice |
8 |
| Gestational Diabetes Mellitus (GDM) - Diagnosis, Treatment and Follow-Up. Guideline of the DDG and DGGG (S3 Level, AWMF Registry Number 057/ February 2018) |
7 |
| Advances in Understanding the Immune Imbalance between T-Lymphocyte Subsets and NK Cells in Recurrent Spontaneous Abortion |
7 |
| Update Breast Cancer 2019 Part 4-Diagnostic and Therapeutic Challenges of New, Personalised Therapies for Patients with Early Breast Cancer |
6 |
| Concept Paper on the Technique of Cryopreservation, Removal and Transplantation of Ovarian Tissue for Fertility Preservation |
6 |
| Update Breast Cancer 2019 Part 5-Diagnostic and Therapeutic Challenges of New, Personalised Therapies in Patients with Advanced Breast Cancer |
6 |
| Possible Reasons for Discontinuation of Therapy: an Analysis of 571071 Treatment Cycles From the German IVF Registry |
6 |
| Mindfulness-based Stress Reduction in Pregnancy: an App-Based Programme to Improve the Health of Mothers and Children (MINDFUL/PMI Study) |
6 |
| Serum Vitamin D Levels in Fertile and Infertile Women with Polycystic Ovary Syndrome |
5 |
| Circulating and Disseminated Tumor Cells in Breast Carcinoma Report from the Consensus Conference on Tumor Cell Dissemination during the 39th Annual Meeting of the German Society of Senology, Berlin, 27 June 2019 |
5 |
| Update Breast Cancer 2019 Part 1-Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer |
5 |
| Methylenetetrahydrofolate Reductase Polymorphisms and Pregnancy Outcome |
5 |
| Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities |
5 |
| Role of Indocyanine Green in Fluorescence Imaging with Near-Infrared Light to Identify Sentinel Lymph Nodes, Lymphatic Vessels and Pathways Prior to Surgery - A Critical Evaluation of Options |
4 |
| Prevention of Cervical Cancer Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia |
4 |
| Progesterone for the Prevention of Preterm Birth - an Update of Evidence-Based Indications |
4 |
| New Aspects in the Diagnosis and Therapy of Fetal Hypoplastic Left Heart Syndrome |
4 |
| Analysis of GDF15 and IGFBP7 in Hyperemesis Gravidarum Support Causality |
4 |
| Tuberculosis in Pregnancy - a Summary |
4 |
| Coagulation Biomarkers inWomen with Recurrent Miscarriage and Polycystic Ovarian Syndrome: Systematic Review and Meta-Analysis |
4 |
| Use of Bladder Filling to Prevent Urinary System Complications in the Management of Placenta Percreta: a Randomized Prospective Study |
3 |
| Does an Immigrant Background Affect the Indication, Incidence or Outcome of Emergency Cesarean Section? Results of the Prospective Data Collection of 111 Births |
3 |
| Standards Used by a Clinical and Scientific Endometriosis Center for the Diagnosis and Therapy of Patients with Endometriosis |
3 |
| Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention |
3 |
| Diagnosis and Therapy Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015- February 2019) - Part Basic Assessment of the Woman |
3 |
| Translational Highlights in Breast and Ovarian Cancer 2019-Immunotherapy, DNA Repair, PI3K Inhibition and CDK4/6 Therapy |
3 |
| Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/ February 2019) - Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm Birth |
3 |
| Prevention of Cervical Cancer Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-up |
3 |
| Evidence GDF15 Plays a Role in Familial and Recurrent Hyperemesis Gravidarum |
3 |
| Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/ February 2019) |
3 |
| Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/ October 2018) |
3 |
| Neoadjuvant Therapy of Cervical Carcinoma with the Angiogenesis Inhibitor Bevacizumab: a Single-Centre Analysis |
2 |
| Follicular Fluid Levels of Adrenomedullin Vascular Endothelial Growth Factor and its Soluble Receptors Are Associated with Ovarian Response During ART Cycles |
2 |
| Controversies about the Secondary Prevention of Spontaneous Preterm Birth |
2 |
| Placenta - Worth Trying? Human Maternal Placentophagia: Possible Benefit and Potential Risks |
2 |
| Circulating and Disseminated Tumour Cells in Breast Carcinoma Report from the Consensus Conference on Tumour Cell Dissemination during the 38th Annual Meeting of the German Society of Senology, Berlin, 14 June 2018 |
2 |
| Management of Urethral Lesions and Urethrovaginal Fistula Formation Following Placement of a Tension-Free Suburethral Sling: Evaluation From a University Continence and Pelvic Floor Centre |
2 |
| Rescue Adjuvant Vaginal Progesterone May Improve Outcomes in Cervical Cerclage Failure |
2 |
| Opportunistic Salpingectomy at the Time of Benign Laparoscopic Hysterectomy: Assessment of Possible Complications and Histopathological p53-Signatures |
2 |
